Net profit of Windlas Biotech rose 3.18% to Rs 15.58 crore in the quarter ended December 2024 as against Rs 15.10 crore during the previous quarter ended December 2023. Sales rose 20.23% to Rs 195.02 crore in the quarter ended December 2024 as against Rs 162.21 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 195.02 | 162.21 | 20 |
| OPM % | 12.63 | 12.54 | - |
| PBDT | 27.28 | 23.20 | 18 |
| PBT | 20.34 | 19.81 | 3 |
| NP | 15.58 | 15.10 | 3 |